All Resources

Economic Impact • May 12, 2025

The Canadian Research and Development Pharmaceutical Sector, 2022

Learn more | View

Access to Medicine • March 10, 2025

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget…

Learn more | View

Access to Medicine • January 30, 2025

Increasing Access to Innovative Medicines

2025 Ontario Budget…

Learn more | View

Intellectual Property • November 06, 2024

Submission on Global Affairs Canada CUMSA Consultation

Learn more | View

Private Drug Coverage • November 04, 2024

Issues and Opportunities to Modernize Private Drug Plan Sustainability 2024

Learn more | View

Economic Impact • July 29, 2024

The Canadian Research & Development Pharmaceutical Sector 2021

Learn more | View

Pharmacare • May 23, 2024

IMC Submission to the Standing Committee of Health on Bill C-64

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024

IMC Response to the PMPRB’s 2023 Scoping Paper for the Consultations on the Board’s Guidelines

Learn more | View

Private Drug Coverage • September 15, 2023

Cost of A Private Drug Plan Claim

Learn more | View

September 08, 2023

Submission on Consultation regarding Patent Term Adjustment (PTA) Regulations

Learn more | View

Access to Medicine • August 21, 2023

IMC Response to the PMPRB’s 2023 Interim Guidance Consultation

Learn more | View

June 08, 2023

Submission for the parliamentary consultations on Bill 15—An Act to Make the Health and Social Services more effective

Learn more | View